These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22786495)

  • 21. Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD008308. PubMed ID: 21563168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2007 Oct; (4):CD002057. PubMed ID: 17943765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.
    Ng G; da Silva O; Ohlsson A
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003214. PubMed ID: 22696334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.
    Cools F; Henderson-Smart DJ; Offringa M; Askie LM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD000104. PubMed ID: 19588317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
    Lemyre B; Davis PG; De Paoli AG; Kirpalani H
    Cochrane Database Syst Rev; 2014 Sep; (9):CD003212. PubMed ID: 25188554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cromolyn sodium for the prevention of chronic lung disease in preterm infants.
    Ng G; Ohlsson A
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003059. PubMed ID: 22696332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants.
    Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001079. PubMed ID: 10796410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Shah SS; Ohlsson A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004213. PubMed ID: 16437478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal derived surfactant extract for treatment of respiratory distress syndrome.
    Seger N; Soll R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surfactant for meconium aspiration syndrome in full term/near term infants.
    El Shahed AI; Dargaville P; Ohlsson A; Soll RF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002054. PubMed ID: 17636695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.
    Henderson-Smart DJ; Cools F; Bhuta T; Offringa M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000104. PubMed ID: 17636590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
    Yost CC; Soll RF
    Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
    Soll RF; Morley CJ
    Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2011 Jul; (7):CD004213. PubMed ID: 21735396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
    Ohlsson A; Aher SM
    Cochrane Database Syst Rev; 2014 Apr; (4):CD004863. PubMed ID: 24771408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome.
    Abdel-Latif ME; Osborn DA
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008311. PubMed ID: 21412918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R; Ozek E
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.